Li Tingting, Han Liang, Ma Simin, Lin Weiji, Ba Xin, Yan Jiahui, Huang Ying, Tu Shenghao, Qin Kai
Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Nosocomial Infection Management, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Mol Biosci. 2023 Mar 6;10:1140325. doi: 10.3389/fmolb.2023.1140325. eCollection 2023.
Colorectal cancer (CRC) is one of the most common malignancies worldwide and the second leading cause of cancer-related death. In recent years, the relationship between gut microbiota and CRC has attracted increasing attention from researchers. Studies reported that changes in the composition of gut microbiota, such as increase in the number of and , impair the immune surveillance by affecting the intestinal mucosal immunity and increase the risk of tumor initiation and progression. The tumor microenvironment is the soil for tumor survival. Close contacts between gut microbiota and the tumor microenvironment may directly affect the progression of tumors and efficacy of antitumor drugs, thus influencing the prognosis of patients with CRC. Recently, many studies have shown that traditional Chinese medicine can safely and effectively improve the efficacy of antitumor drugs, potentially through remodeling of the tumor microenvironment by regulated gut microbiota. This article describes the effect of gut microbiota on the tumor microenvironment and possible mechanisms concerning the initiation and progression of CRC, and summarizes the potential role of traditional Chinese medicine.
结直肠癌(CRC)是全球最常见的恶性肿瘤之一,也是癌症相关死亡的第二大主要原因。近年来,肠道微生物群与结直肠癌之间的关系引起了研究人员越来越多的关注。研究报告称,肠道微生物群组成的变化,如[具体微生物名称1]和[具体微生物名称2]数量的增加,会通过影响肠道黏膜免疫损害免疫监视,并增加肿瘤发生和进展的风险。肿瘤微环境是肿瘤生存的土壤。肠道微生物群与肿瘤微环境之间的密切接触可能直接影响肿瘤的进展和抗肿瘤药物的疗效,从而影响结直肠癌患者的预后。最近,许多研究表明,中药可以安全有效地提高抗肿瘤药物的疗效,可能是通过调节肠道微生物群重塑肿瘤微环境来实现的。本文描述了肠道微生物群对肿瘤微环境的影响以及与结直肠癌发生和进展相关的可能机制,并总结了中药的潜在作用。